Global Blood Plasma Derivatives market is expected to reach US$ 30.5 billion by 2023

Global Blood Plasma Derivatives Information by type (Albumin, Anti-Thrombin III, Intravenous immunoglobulin (IVIG), Fresh Frozen Plasma (FFP) and others), by application (Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others), by end users (Hospitals, clinics, diagnostic centers, blood transfusion centers and others- Forecast to 2023

Market Highlights

Increasing incidences of thrombocytosis and related complication is a major driver for the growth of blood plasma market throughout the globe. Center for Disease Control (CDC) and the National Institutes of Health (NIH) conducts awareness programs for prevented thrombocytosis and related complications Global Blood Plasma Derivatives market was about is expected to reach US$ 30.5 billion by 2023 at a CAGR of 7.52% during forecast period 2017 to 2023.

Major Market Players:

  • Grifols (Germany),
  • SK Plasma (Korea),
  • Fusion Healthcare (India),
  • Baxter International Inc. (U.S),
  • CSL Limited (Australia).
  • Octapharma AG (Germany),
  • Biotest AG (Germany),
  • Bain Capital (U.S).

Grifols is a leading producer of blood plasma derived protein therapies for patients who have rare genetic diseases. It has plasma donation 147 plasma donation centers across the world.

SK Plasma products include Liv- Gamma Inj. (human IgG solution) and ETBI Inj. (Plasma derived coagulation Factor VIII)

Fusion Healthcare manufactures a product named Genexglob (Normal human immunoglobulin Inj. 5g).

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1325

Regional Analysis:

Globally, Blood Plasma Derivatives market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa. North America is segmented into countries into namely the U.S., Canada and Mexico. Europe market consists of countries namely U.K. France, Germany, Italy, Spain and Rest of Europe. Asia-Pacific market consists of countries namely India, China, Japan, Australia, Republic of Korea and Rest of Asia-Pacific and Middle East and Africa consists of countries namely United Arab Emirates, Saudi Arabia, Turkey and Rest of Middle East and Africa. North America is expected to be the largest market for blood plasma derivatives. Increase in awareness regarding incidences of thrombocytosis and use of plasma derivatives to kill viruses causing infectious diseases favor the growth of market in this region. Demand for technological advancement in plasma derived products and extensive research in production of plasma derivatives initiate the growth of this market in Europe. Asia-Pacific is expected to show fastest growth because of increase in prevalence of infectious diseases and emphasis on safe blood transfusion procedure. Countries in Middle East and Africa mostly export plasma derived products from the North American and European countries.

Test the market data and market information presented through more than 45 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Blood Plasma Derivatives market Research Report –Global Forecast to 2023.”

Report Details @ https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market-1325   

Global Blood Plasma Derivatives market has been segmented on the basis of type which includes albumin, anti-thrombin, intravenous immunoglobulin (IVIG), fresh frozen plasma (FFP) and others. Others types are Factor VII, Factor IX and Alpha 1 proteinase inhibitor concentrate. On the basis on application the market is segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease. End users include hospitals, clinics, diagnostic centers, blood transfusion centers and others.

Table of Content

1        Report Prologue   

2         Market Introduction   

2.1      Introduction   

2.2      Scope of Study   

2.3      Research Objective   

2.4       Assumptions & Limitations   

2.4.1    Assumptions   

2.4.2    Limitations   

3           Research Methodology   

Continued……

Browse Related Statistical Report

The Global connected healthcare market has been evaluated as growing market and expected that the market will touch high growth figures. On the basis of type, the market is segmented into; M-health devices, M-health services and E-prescription. The M-Health Services holds 56.7% market share and expected to reach USD 59.05 billion by 2022 from USD 6.80 billion in 2015. E-prescription is expected to grow at a fastest CAGR of 30.84% from 2016 to 2022.

https://www.marketresearchfuture.com/statistical-reports/connected-healthcare-market-value-2666

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

 

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market